English
FranįaisObbligazione Royalty Pharma 3.3% ( US78081BAL71 ) in USD
| Emittente | Royalty Pharma | ||||
| Prezzo di mercato |  100.00 USD ▲ |
||||
| Paese |  Stati Uniti
|
||||
| Codice isin |
 US78081BAL71 ( in USD )
|
||||
| Tasso d'interesse | 3.3% per anno ( pagato 2 volte l'anno) | ||||
| Scadenza | 02/09/2040 | ||||
|
La brochure del prospetto in formato PDF |
|||||
| Importo minimo | 2 000 USD | ||||
| Importo totale | 1 000 000 000 USD | ||||
| Cusip | 78081BAL7 | ||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||
| Moody's rating | Baa3 ( Lower medium grade - Investment-grade ) | ||||
| Coupon successivo | 02/03/2027 ( In 167 giorni ) | ||||
| Descrizione dettagliata |
Royalty Pharma č una societā di investimento biofarmaceutico che acquista diritti di royalty su farmaci giā approvati. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAL71, pays a coupon of 3.3% per year. The coupons are paid 2 times per year and the Obbligazione maturity is 02/09/2040 The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAL71, was rated Baa3 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAL71, was rated BBB- ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||